Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

Journal of Lipid Research

Volumn 40, Issue 1, 1999, Pages 1-16

  Mahley, Robert W ^a   Ji, Zhong Sheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein E; Heparan sulfate proteoglycans; Hepatic lipase; Lipoprotein lipase; Remnants

Indexed keywords

APOLIPOPROTEIN E; CHYLOMICRON; HEPARAN SULFATE; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOGLYCAN;

ANIMAL CELL; CELL SURFACE; CHO CELL; CHOLESTEROL BLOOD LEVEL; ENDOCYTOSIS; ENZYME LOCALIZATION; LIGAND BINDING; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RABBIT; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CHYLOMICRONS; ENDOCYTOSIS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; LDL-RECEPTOR RELATED PROTEIN 1; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIVER; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL;

EID: 0032895028     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Mahley, R. W. 1985. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. Circulation. 72: 943-948.
2. Mahley, R. W., K. H. Weisgraber, T. L. Innerarity, and S. C. Rall, Jr. 1991. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. J. Am. Med. Assoc. 265: 78-83.
3. Mahley, R. W., K. H. Weisgraber, and R. V. Farese, Jr. 1998. Disorders of lipid metabolism. In Williams Textbook of Endocrinology. 9th edition. J. D. Wilson, D. W. Foster, H. M. Kronenberg, and P. R. Larsen, editors. W.B. Saunders, Philadelphia. 1099-1153.
4. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
5. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
6. Hui, D. Y., T. L. Innerarity, and R. W. Mahley. 1981. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apoE and apoB,E receptors. J. Biol. Chem. 256: 5646-5655.
7. Hui, D. Y., T. L. Innerarity, R. W. Milne, Y. L. Marcel, and R. W. Mahley. 1984. Binding of chylomicron remnants and β-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J. Biol. Chem. 259: 15060-15068.
8. Herz, J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K. K. Stanley. 1988. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7: 4119-4127.
9. 2-macroglobulin receptor. FEBS Lett. 276: 151-155.
10. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265: 17401-17404.
11. Herz, J. 1993. The LDL-receptor-related protein - portrait of a multifunctional receptor. Curr. Opin. Lipidol. 4: 107-113.
12. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63: 601-637.
13. Herz, J., and T. E. Willnow. 1995. Lipoprotein and receptor interactions in vivo. Curr. Opin. Lipidol. 6: 97-103.
14. Schneider, W. J., J. Nimpf, and H. Bujo. 1997. Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr. Opin. Lipidol. 8: 315-319.
15. Windler, E., J. Greeve, B. Levkau, V. Kolb-Bachofen, W. Daerr, and H. Greten. 1991. The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem. J. 276: 79-87.
16. Bihain, B. E., and F. T. Yen. 1992. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Biochemistry. 31: 4628-4636.
17. Yen, F. T., C. J. Mann, L. M. Guermani, N. F. Hannouche, N. Hubert, C. A. Hornick, V. N. Bordeau, G. Agnani, and B. E. Bihain. 1994. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry. 33: 1172-1180.
18. Mann, C. J., J. Khallou, O. Chevreuil, A. A. Troussard, L. M. Guermani, K. Launay, B. Delplanque, F. T. Yen, and B. E. Bihain. 1995. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Biochemistry. 34: 10421-10431.
19. Troussard, A. A., J. Khallou, C. J. Mann, P. André, D. K. Strickland, B. E. Bihain, and F. T. Yen. 1995. Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein. J. Biol. Chem. 270: 17068-17071.
20. 2-macroglobulin-recognition site. Biochem. J. 279: 863-870.
21. Ziere, G. J., J. K. Kruijt, M. K. Bijsterbosch, and T. J. C. van Berkel. 1996. Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor. Biochem. J. 313: 289-295.
22. Gianturco, S. H., M. P. Ramprasad, A. H-Y. Lin, R. Song, and W. A. Bradley. 1994. Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J. Lipid Res. 35: 1674-1687.
23. Ramprasad, M. P., R. Li, W. A. Bradley, and S. H. Gianturco. 1995. Human THP-1 monocyte-macrophage membrane binding proteins: distinct receptor(s) for triglyceride-rich lipoproteins. Biochemistry. 34: 9126-9135.
24. Mahley, R. W., and S. C. Rall, Jr. 1995. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease. 7th edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1953-1980.
25. Mahley, R. W. 1996. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr. J. Med. Sci. 32: 414-429.
26. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
27. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
28. Mahley, R. W., Z-S. Ji, W. J. Brecht, R. D. Miranda, and D. He. 1994. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann. NY Acad. Sci. 737: 39-52.
29. Ji, Z-S., S. J. Lauer, S. Fazio, A. Bensadoun, J. M. Taylor, and R. W. Mahley. 1994. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269: 13429-13436.
30. Shafi, S., S. E. Brady, A. Bensadoun, and R. J. Havel. 1994. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35: 709-720.
31. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
32. Mulder, M., P. Lombardi, H. Jansen, T. J. C. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268: 9369-9375.
33. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192.
34. Willnow, T. E. 1997. Mechanisms of hepatic chylomicron remnant clearance. Diabet. Med. 14 (Suppl. 3): S75-S80.
35. Ji, Z-S., S. Fazio, Y-L. Lee, and R. W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269: 2764-2772.
36. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
37. Ji, Z-S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36: 583-592.
38. Hussain, M. M., R. K. Kancha, Z. Zhou, J. Luchoomun, H. Zu, and A. Bakillah. 1996. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta. 1300: 151-170.
39. Fraser, R., B. R. Dobbs, and G. W. T. Rogers. 1995. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology. 21: 863-874.
40. Hamilton, R. L., J. S. Wong, L. S. S. Guo, S. Krisans, and R. J. Havel. 1990. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid Res. 31: 1589-1603.
41. Stow, J. L., L. Kjéllen, E. Unger, M. Höök, and M. G. Farquhar. 1985. Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes. J. Cell Biol. 100: 975-980.
42. Sanan, D. A., J. Fan, A. Bensadoun, and J. M. Taylor. 1997. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J. Lipid Res. 38: 1002-1013.
43. Vilaró, S., I. Ramírez, G. Bengtsson-Olivecrona, T. Olivecrona, and M. Llobera. 1988. Lipoprotein lipase in liver. Release by heparin and immunocytochemical localization. Biochim. Biophys. Acta. 959: 106-117.
44. Choi, S. Y., L. G. Fong, M. J. Kirven, and A. D. Cooper. 1991. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88: 1173-1181.
45. 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo. J. Biol. Chem. 268: 15804-15811.
46. Ishibashi, S., J. Herz, N. Maeda, J. L. Goldstein, and M. S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91: 4431-4435.
47. Herz, J., S-Q. Qiu, A. Oesterle, H. V. de Silva, S. Shafi, and R. J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92: 4611-4615.
48. Rohlmann, A., M. Gotthardt, R. E. Hammer, and J. Herz. 1998. Inducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101: 689-695.
49. Mortimer, B-C., D. J. Beveridge, I. J. Martins, and T. C. Redgrave. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway. J. Biol. Chem. 270: 28767-28776.
50. Mahley, R. W., K. H. Weisgraber, M. M. Hussain, B. Greenman, M. Fisher, T. Vogel, and M. Gorecki. 1989. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83: 2125-2130.
51. Shimano, H., Y. Namba, J. Ohsuga, M. Kawamura, K. Yamamoto, M. Shimada, T. Gotoda, K. Harada, Y. Yazaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93: 2215-2223.
52. Fan, J., Z.-S. Ji, Y. Huang, H. de Silva, D. Sanan, R. W. Mahley, T. L. Innerarity, and J. M. Taylor. 1998. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J. Clin. Invest. 101: 2151-2164.
53. Fazio, S., Y-L. Lee, Z-S. Ji, and S. C. Rall, Jr. 1993. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J. Clin. Invest. 92: 1497-1503.
54. Rall, S. C., Jr., Y. M. Newhouse, H. R. G. Clarke, K. H. Weisgraber, B. J. McCarthy, R. W. Mahley, and T. P. Bersot. 1989. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J. Clin. Invest. 83: 1095-1101.
55. Horie, Y., S. Fazio, J. R. Westerlund, K. H. Weisgraber, and S. C. Rall, Jr. 1992. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J. Biol. Chem. 267: 1962-1968.
56. Chung, B. H., and J. P. Segrest. 1983. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction. J. Lipid Res. 24: 1148-1159.
57. Ehnholm, C., R. W. Mahley, D. A. Chappell, K. H. Weisgraber, E. Ludwig, and J. L. Witztum. 1984. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA. 81: 5566-5570.
58. Mulder, M., H. van der Boom, P. de Knijff, C. Braam, A. van den Maagdenberg, J. A. Gevers Leuven, and L. M. Havekes. 1994. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146→Gln) are inefficiently converted to cholesterol-rich lipoproteins. Atherosclerosis. 108: 183-192.
59. Huang, Y., S. C. Rall, Jr., and R. W. Mahley. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler. Thromb. Vasc. Biol. 17: 2817-2824.
60. Huang, Y., X. Q. Liu, S. C. Rall, Jr., and R. W. Mahley. 1998. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J. Biol. Chem. 273: 17483-17490.
61. Kuusi, T., E. A. Nikkilä, I. Virtanen, and P. K. J. Kinnunen. 1979. Localization of the heparin-releasable lipase in situ in the rat liver. Biochem. J. 181: 245-246.
62. van Tol, A., and T. J. C. van Berkel. 1980. Uptake and degradation of rat and human very low density (remnant) apolipoprotein by parenchymal and non-parenchymal rat liver cells. Biochim. Biophys. Acta. 619: 156-166.
63. Hornick, C. A., C. Thouron, J. G. DeLamatre, and J. Huang. 1992. Triacylglycerol hydrolysis in isolated hepatic endosomes. J. Biol. Chem. 267: 3396-3401.
64. Kounnas, M. Z., D. A. Chappell, H. Wong, W. S. Argraves, and D. K. Strickland. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270: 9307-9312.
65. Applebaum-Bowden, D. 1995. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr. Opin. Lipidol. 6: 130-135.
66. Krapp, A., S. Ahle, S. Kersting, Y. Hua, K. Kneser, M. Nielsen, J. Gliemann, and U. Beisiegel. 1996. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37: 926-936.
67. Komaromy, M., S. Azhar, and A. D. Cooper. 1996. Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester. J. Biol. Chem. 271: 16906-16914.
68. Huff, M. W., D. B. Miller, B. M. Wolfe, P. W. Connelly, and C. G. Sawyez. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J. Lipid Res. 38: 1318-1333.
69. Brasaemle, D. L., K. Cornely-Moss, and A. Bensadoun. 1993. Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J. Lipid Res. 34: 455-465.
70. Chang, S., and J. Borensztajn. 1993. Hepatic lipase function and the accumulation of β-very-low-density lipoproteins in the plasma of cholesterol-fed rabbits. Biochem. J. 293: 745-750.
71. Daggy, B. P., and A. Bensadoun. 1986. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim. Biophys. Acta. 877: 252-261.
72. Kuusi, T., P. K. J. Kinnunen, and E. A. Nikkilä. 1979. Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo. FEBS Lett. 104: 384-388.
73. de Faria, E., L. G. Fong, M. Komaromy, and A. D. Cooper. 1996. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J. Lipid Res. 37: 197-209.
74. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
75. Felts, J. M., H. Itakura, and R. T. Crane. 1975. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory. Biochem. Biophys. Res. Commun. 66: 1467-1475.
76. Eisenberg, S., E. Sehayek, T. Olivecrona, and I. Vlodavsky. 1992. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J. Clin. Invest. 90: 2013-2021.
77. Williams, K. J., G. M. Fless, K. A. Petrie, M. L. Snyder, R. W. Brocia, and T. L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein[a], low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267: 13284-13292.
78. 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267: 25764-25767.
79. 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. J. Biol. Chem. 268: 14168-14175.
80. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 268: 15048-15055.
81. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
82. Ghiselli, G., E. J. Schaefer, P. Gascon, and H. B. Brewer, Jr. 1981. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science. 214: 1239-1241.
83. Lohse, P., H. B. Brewer III, M. S. Meng, S. I. Skarlatos, J. C. LaRosa, and H. B. Brewer, Jr. 1992. Familial apolipoprotein E deficiency and type III hyperlipoproteinemia due to a premature stop codon in the apolipoprotein E gene. J. Lipid Res. 33: 1583-1590.
84. Zsigmond, E., E. Scheffler, T. M. Forte, R. Potenz, W. Wu, and L. Chan. 1994. Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size. J. Biol. Chem. 269: 18757-18766.
85. Zsigmond, E., K. Kobayashi, K-W. Tzung, L. Li, Y. Fuke, and L. Chan. 1997. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum. Gene Ther. 8: 1921-1933.
86. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6: 291-305.
87. Williams, K. J., and I. V. Fuki. 1997. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr. Opin. Lipidol. 8: 253-262.
88. Fuki, I. V., K. M. Kuhn, I. R. Lomazov, V. L. Rothman, G. P. Tuszynski, R. V. Iozzo, T. L. Swenson, E. A. Fisher, and K. J. Williams. 1997. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100: 1611-1622.
89. Fernández-Borja, M., D. Bellido, E. Vilella, G. Olivecrona, and S. Vilaró. 1996. Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway. J. Lipid Res. 37: 464-481.
90. Windler, E., J. Greeve, H. Robenek, F. Rinninger, H. Greten, and S. Jäckle. 1996. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology. 24: 344-351.
91. Bu, G., H. J. Geuze, G. J. Strous, and A. L. Schwartz. 1995. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 14: 2269-2280.
92. Willnow, T. E., S. A. Armstrong, R. E. Hammer, and J. Herz. 1995. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. Natl. Acad. Sci. USA. 92: 4537-4541.
93. Willnow, T. E., A. Rohlmann, J. Horton, H. Otani, J. R. Braun, R. E. Hammer, and J. Herz. 1996. RAP, a specialized chaperone, prevents ligand-induceri ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15: 2632-2639.
94. 2-macroglobulin receptor. J. Biol. Chem. 266: 21232-21238.
95. Ji, Z-S., and R. W. Mahley. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14: 2025-2032.
96. Vassiliou, G., and K. K. Stanley. 1994. Exogenous receptor-associated protein binds to two distinct sites on human fibroblasts but does not bind to the glycosaminoglycan residues of heparan sulfate proteoglycans. J. Biol. Chem. 269: 15172-15178.
97. Bernfield, M., R. Kokenyesi, M. Kato, M. T. Hinkes, J. Spring, R. L. Gallo, and E. J. Lose. 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8: 365-393.
98. Kjellén, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60: 443-475.
99. 2-macroglobulin receptor. J. Biol. Chem. 266: 13936-13940.
100. 2-macroglobulin in the rat. J. Lipid Res. 34: 309-315.
101. Jong, M. C., V. E. H. Dahlmans, P. J. J. van Gorp, K. W. van Dijk, M. L. Breuer, and M. H. Hofker. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein CI overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98: 2259-2267.
102. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
103. Linton, M. F., A. H. Hasty, V. R. Babaev, and S. Fazio. 1998. Hepatic apoE, expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J. Clin. Invest. 101: 1726-1736.
104. Zeng, B-J., B-C. Mortimer, I. J. Martins, U. Seydel, and T. G. Redgrave. 1998. Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. J. Lipid Res. 39: 845-860.
105. Herz, J., D. E. Clouthier, and R. E. Hammer. 1992. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 71: 411-421.
106. Jeong, T-S., S. L. Schissel, I. Tabas, H. J. Pownall, A. R. Tall, and X-C. Jiang. 1998. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101: 905-912.
107. Véniant, M. M., C. H. Zlot, R. L. Walzem, V. Pierotti, R. Driscoll, D. Dichek, J. Herz., and S. G. Young. 1998. Lipoprotein clearance mechanisms in LDL receptor-deficient "apo-B48-only" and "apo-B100-only" mice. J. Clin. Invest. 102: 1559-1568.
108. Ji, Z-S., H. L. Dichek, R. D. Miranda, and R. W. Mahley. 1997. Heparan sulfate proteoglycans participate in hepatic lipase- and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 272: 31285-31292.
109. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 252: 1705-1708.
110. Aviezer, D., D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon. 1994. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 79: 1005-1013.
111. Klagsbrun, M., and A. Baird. 1991. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67: 229-231.
112. Reiland, J., and A. C. Rapraeger. 1993. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci. 105: 1085-1093.
113. Gleizes, P-E., J. Noaillac-Depeyre, F. Amalric, and N. Gas. 1995. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach. Eur. J. Cell Biol. 66: 47-59.
114. Ji, Z-S., S. Fazio, and R. W. Mahley. 1994. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type IIII hyperlipoproteinemia. J. Biol. Chem. 269: 13421-13428.
115. Weisgraber, K. H., and R. W. Mahley. 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10: 1485-1494.
116. Mahley, R. W. 1997. Apolipoprotein E: structure and function in lipid metabolism and neurobiology. In The Molecular and Genetic Basis of Neurological Disease. 2nd edition. R. N. Rosenberg, S. B. Prusiner, S. DiMauro, and R. L. Barchi, editors. Butterworth-Heinemann, Boston, 1037-1049.
117. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90: 1977-1981.
118. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261: 921-923.
119. Nathan, B. P., S. Bellosta, D. A. Sanan, K. H. Weisgraber, R. W. Mahley, and R. E. Pitas. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264: 850-852.
120. Bellosta, S., B. P. Nathan, M. Orth, L-M. Dong, R. W. Mahley, and R. E. Pitas. 1995. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270: 27063-27071.
121. Holtzman, D. M., R. E. Pitas, J. Kilbridge, B. Nathan, R. W. Mahley, G. Bu, and A. L. Schwartz. 1995. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92: 9480-9484.
122. Fagan, A. M., G. Bu, Y. Sun, A. Daugherty, and D. M. Holtzman. 1996. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271: 30121-30125.
123. Nathan, B. P., K-C. Chang, S. Bellosta, E. Brisch, N. Ge, R. W. Mahley, and R. E. Pitas. 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270: 19791-19799.
124. Ji, Z-S., R. E. Pitas, and R. W. Mahley. 1998. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 273: 13452-13460.
125. Dichek, H. L., W. Brecht, J. Fan, Z-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, J. M. Taylor, and R. W. Mahley. 1998. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem. 273: 1896-1903.
126. Diard, P., M-I. Malewiak, D. Lagrange, and S. Griglio. 1994. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299: 889-894.